Danette Daniels

Company: Foghorn Therapeutics

Job title: Vice President, Protein Degradation Platform

Seminars:

Targeting Chromatin Modulators with Therapeutic Degraders 1:40 pm

• Applying degradation to achieve selectivity • Exploration of varying E3 ligase activity • Expanding degrader delivery and formulationRead more

day: Conference Day 1 - PM

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.